Serum cholesterol as a marker of nutrition in end-stage renal failure patients on renal replacement therapy

International Journal of Pharmacology

Volumn 2, Issue 2, 2006, Pages 184-187

  Baradaran, Azar ^a   Nasri, Hamid ^b  

^a Hospital Bu Ali   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein (CRP); Cholesterol; End stage renal failure; Hemodialysis

Indexed keywords

ACETIC ACID; ANTILIPEMIC AGENT; BIOMATERIAL; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM CARBONATE; CARNITINE; CHOLESTEROL; CREATININE; FERRIC HYDROXIDE SUCROSE; FOLIC ACID; IRON; POLYSULFONE; RECOMBINANT ERYTHROPOIETIN; SEVELAMER; VITAMIN B COMPLEX;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIALYSIS MEMBRANE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; IRAN; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; TREATMENT DURATION; UREMIA;

EID: 33646184579     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2006.184.187     Document Type: Article

References (25)

1. Aparicio, M., N. Cano and P. Chauveau, 1999. Nutritional status of haemodialysis patients: A French national cooperative study. French study group for nutrition in dialysis. Nephrol. Dial. Transplant., 14: 1679-1686.
2. Bergström, J., 1995. Nutrition and mortality in hemodialysis. J. Am. Soc. Nephrol., 6: 1329-1341.
3. Bergström, J., 1995. Why are dialysis patients malnourished? Am. J. Kidney Dis., 26: 229-241.
4. Bologa, R.M., D.M. Levine and T.S. Parker, 1998. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am. J. Kidney Dis., 32: 107-114.
5. Bossola, M., M. Muscaritoli, V. Valenza, N. Panocchia and L. Tazza et al., 2004. Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin. Pract., 97: 76-82.
6. Caglar, K., R.M. Hakim and A. Ikizler, 2002. Approaches to the reversal of malnutrition, inflammation and atherosclerosis in end-stage renal disease. Nutr. Rev., 60: 378-387.
7. Clyne, B. and J.S. Olshaker, 1999. The C-reactive protein. J. Emerg. Med., 17: 1019-1025.
8. Fox, C.S., J.C. Longenecker, N.R. Powe, M.J. Klag and N.E. Fink et al., 2004. CHOICE Study. Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients. Clin. Nephrol., 61: 299-307.
9. Fujino, Y., E. Ishimura, S. Okuno, N. Tsuboniwa, K. Maekawa and T. Izumotani, 2005. C-reactive protein is a significant predictor of decrease in fat mass in hemodialysis patients. Biomed. Pharmacother., 59: 264-268.
10. Gillett, M.P., E.N. Obineche, S.T. Khan and A.M. Abdulle, 2004. Plasma concentrations of non-esterifled fatty acids in chronic renal failure in the United Arab Emirates. Saudi Med. J., 25: 1611-1616.
11. Haubitz, M., R. Brunkhorst, E. Wrenger, P. Froese, M. Schulze and K.M. Koch, 1996. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit. Dial. Intl., 16: 158-162.
12. Ikizler, T.A., R.L. Wingard, J. Harvell, Y. Shyr and R.M. Hakim, 1999. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Intl., 55: 1945-1951.
13. Kalantar-Zadeh, K., G. Block, M.H. Humphreys and J.D. Kopple, 2003. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Intl., 63: 793-808.
14. Kalantar-Zadeh, K., K.C. Abbott, A.K. Salahudeen, R.D. Kilpatrick and T.B. Horwich, 2005. Survival advantages of obesity in dialysis patients. Am. J. Clin. Nutr., 81: 543-554.
15. Liu, Y., J. Coresh, J.A. Eustace, J.C. Longenecker and B. Jaar et al., 2004. Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA., 291: 451-459.
16. McIntyre, C., I. Harper, I.C. Macdougall, A.E. Raine, A. Williams and L.R. Baker, 1997. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin. Nephrol., 48: 371-374.
17. Morrow, D.A. and P.M. Ridker, 2000. C-reactive protein inflammation and coronary risk. Med. Clin. North. Am., 84: 149-161.
18. Nasri, H. and A. Baradaran, 2004. Correlation of serum magnesium with dyslipidemia in maintenance hemodialysis patients. Acta Medica (Hradec Kralove), 47: 263-265.
19. Qureshi, A.R., A. Alvestrand and A. Danielsson, 1998. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Intl., 53: 773-782.
20. Stenvinkel, P., O. Heimburger and F. Paultre, 1999. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Intl., 55: 1899-1911.
21. Stenvinkel, P., P. Barany, O. Heimburger, R. PecoitsFilho, B. Lindholm, 2002. Mortality, malnutrition and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Intl., 61: 103-108.
22. Warner, C., J. Zimmermann, S. Schwedler and T. Metzger, 2002. Inflammation and cardiovascular risk in dialysis patients. Kidney Intl., 61: 99-102.
23. Wolbink, G.J., M.C. Brouwer, S. Buysmann, I.J. Ten Berge and C.E. Hack, 1996. CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol., 157: 473-479.
24. Yeun, J.Y., R.A. Levine, V. Mantadilok and G.A. Kaysen, 2000. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis., 35: 469-476.
25. Zimmermann, J., S. Herrlinger, A. Pruy, T. Metzger and C. Wanner, 1999. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Intl., 55: 648-658.